Glenmark Pharmaceuticals ltd
GLENMARK · ISIN: INE935A01035
Constituent of NIFTY 100 TRI (0.20%), NIFTY 500 TRI (0.17%), NIFTY LMC 250 TRI (0.40%), NIFTY MC 150 TRI (0.81%), NIFTY SC 250 TRI (1.26%)
Earnings (TTM)
CHART
Glenmark Pharmaceuticals ltd - revenue & profit (TTM)
Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.
15.43%
EBITDA Margin (TTM)
63.71
EPS (TTM)
2.76%
EPS Growth (5Y)
1.92%
EPS Growth (10Y)
Technicals
64.46
RSI (14)
2302.74
SMA (50)
2161.41
SMA (200)
25.53
ADX (14)
2537.6
52-Week High
1792.6
52-Week Low
28.96%
1Y Return
127.1936
Avg Traded Value (20D, ₹Cr)
As of 2026-09-08.
Shareholding Pattern
CHART
Shareholding by category
As of 2026-06-30.
F&O Sentiment
Nearest expiry: 2026-09-29 · As of 2026-09-07.
0.6042
PCR (OI)
0.2479
PCR (Volume)
2400
Max Pain Strike
Corporate Actions
No corporate actions on record for this stock.
Recent Deals
No recent block/bulk/short-sell deals on record for this stock.
Stock data · Not financial advice · Past performance does not indicate future returns